Phased financing through share acquisition rights subject to share price and Triple 25 achievement conditions
First written in FY2017-Q1. 12 of 13 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Proceeds from the exercise of share acquisition rights 9 102」
During the consolidated fiscal year, proceeds of ¥102 million from the exercise of share acquisition rights were recorded, indicating progress in the exercise of performance-linked share acquisition rights. - FY2026-H1AdvancedAnnual report
「Proceeds from the exercise of share acquisition rights 9 102」
During the six-month consolidated accounting period, proceeds of ¥102 million from the exercise of share acquisition rights were recorded, advancing phased financing. - FY2025AdvancedAnnual report
「Other (exercise of share acquisition rights) 625,000 247」
The fiscal year disclosure records the delivery of 625,000 treasury shares upon the exercise of share acquisition rights and a ¥247 million capital transaction, indicating progress in the exercise of performance-linked share acquisition rights. - FY2020-Q1AdvancedAnnual report
「The increase in the total number of issued shares resulted from the exercise of share acquisition rights.」
During the first quarter, 58,800 shares were added through the exercise of share acquisition rights, and contingent, phased financing continued to be realized. - FY2019AdvancedAnnual report
「The increase of 669,200 in the number of issued common shares resulted from the exercise of share acquisition rights.」
From April 2018 through March 2019, 669,200 shares were issued through the exercise of share acquisition rights, further advancing phased financing. - FY2019-Q2AdvancedAnnual report
「1 July 2018–30 September 2018 (Note 1) 459,200 (Note 1) Increase due to the exercise of share acquisition rights.」
From July through September 2018, 459,200 shares were added through the exercise of share acquisition rights, further advancing phased financing and share issuance. - FY2019-Q1AdvancedAnnual report
「Change in total number of issued shares 210,000 (Note) Increase due to the exercise of share acquisition rights.」
From April through June 2018, 210,000 shares were added through the exercise of share acquisition rights, further advancing contingent, phased financing. - FY2018AdvancedAnnual report
「During the consolidated fiscal year, all 18,500 Fifth Series Share Acquisition Rights were exercised by the allottees.」
All 18,500 Fifth Series Share Acquisition Rights, representing 3,700,000 potential shares, were exercised, advancing contingent, phased financing. - FY2018-Q3AdvancedAnnual report
「This was mainly due to ¥1.384937 billion in expenditure for repayment of long-term borrowings and ¥2.601694 billion in proceeds from the issuance of shares through the exercise of share acquisition rights.」
Proceeds of ¥2.601694 billion from the issuance of shares through the exercise of share acquisition rights were recorded, further advancing contingent, phased financing. - FY2018-Q1AdvancedAnnual report
「All 1,850,000 shares underlying the Fifth Series Share Acquisition Rights issued on 22 July 2016 were exercised between 17 May and 31 May 2017, at the exercise dates, class of shares, exercise price, number of shares and total payment amounts shown below.」
All 1,850,000 shares underlying the Fifth Series Share Acquisition Rights were exercised between 17 May and 31 May 2017, generating financing of ¥2.59365 billion in total payments. - FY2017-Q3AdvancedAnnual report
「1 October 2016–31 December 2016 (Note) 245,000 (Note) Increase due to the exercise of share acquisition rights.」
During the third quarter accounting period, 245,000 shares were added through the exercise of share acquisition rights, further advancing contingent, phased issuance of shares. - FY2017-Q2AdvancedAnnual report
「During the second quarter accounting period, the stock acquisition rights related to bonds with stock acquisition rights subject to conditions for revising the exercise price were exercised as follows.」
During the quarter, 12,000 rights were exercised and 1,200,000 shares were delivered, generating financing of ¥1.3215 billion. Contingent, phased financing is progressing in concrete terms. - FY2017-Q1First statedAnnual report
「Under this financing method, funds are raised in connection with the achievement of a specified share price level and the “Triple 25” targets.」
The company designed an issuance of share acquisition rights incorporating achievement of a specified share price level and the Triple 25 targets as exercise conditions, with financing to be conducted from 25 July 2016 through 30 December 2019. The estimated net proceeds were ¥10,396,678,000.